During the last session, Aethlon Medical Inc (NASDAQ:AEMD)’s traded shares were 18.94 million, with the beta value of the company hitting 1.75. At the end of the trading day, the stock’s price was $0.86, reflecting an intraday gain of 30.16% or $0.2. The 52-week high for the AEMD share is $2.29, that puts it down -166.28 from that peak though still a striking 72.09% gain since the share price plummeted to a 52-week low of $0.24. The company’s market capitalization is $15.63M, and the average intraday trading volume over the past 10 days was 16.37 million shares, and the average trade volume was 2.57 million shares over the past three months.
Aethlon Medical Inc (AEMD) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.00. AEMD has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Aethlon Medical Inc (NASDAQ:AEMD) trade information
Aethlon Medical Inc (AEMD) registered a 30.16% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 30.16% in intraday trading to $0.86, hitting a weekly high. The stock’s 5-day price performance is 55.35%, and it has moved by 108.74% in 30 days. Based on these gigs, the overall price performance for the year is -60.73%. The short interest in Aethlon Medical Inc (NASDAQ:AEMD) is 0.29 million shares and it means that shorts have 0.98 day(s) to cover.
Aethlon Medical Inc (AEMD) estimates and forecasts
Statistics show that Aethlon Medical Inc has outperformed its competitors in share price, compared to the industry in which it operates. Aethlon Medical Inc (AEMD) shares have gone up 105.79% during the last six months, with a year-to-date growth rate more than the industry average at 79.22% against -4.50.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 37.58%. While earnings are projected to return 80.04% in 2025.
AEMD Dividends
Aethlon Medical Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Aethlon Medical Inc (NASDAQ:AEMD)’s Major holders
Aethlon Medical Inc insiders own 0.54% of total outstanding shares while institutional holders control 3.09%, with the float percentage being 3.11%.